Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: We turned a profit!

"... we don't know if Barco is included in the proceeds..."

The 10Q says:
"...the Barco case was dismissed with prejudice on November 30, 2012."

But here you can read:
"PDS recognizes revenue from technology license agreements at the time a contract is entered into, the license method is determined (paid-in-advance or on-going royalty), obligations under the license agreement are satisfied, and the realization of revenue is assured which is generally upon the receipt of the license proceeds.

PDS may at times enter into license agreements whereby contingent revenues are recognized as one or more contractual milestones are met."

I doubt Barco is in the 10Q, simply because of the needed time between dismissal (Nov 30) and a finalisation of a contract but of course I have no proof.

Share
New Message
Please login to post a reply